{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:50:14Z","timestamp":1788263414057,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1205802"],"award-info":[{"award-number":["2022YFA1205802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130060"],"award-info":[{"award-number":["82130060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073804"],"award-info":[{"award-number":["82073804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.actbio.2025.07.055","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T06:51:46Z","timestamp":1753426306000},"page":"591-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Quaternary ammonium salt microspheres loaded with vascular disrupting agents for targeted interventional therapy of hepatocellular carcinoma"],"prefix":"10.1016","volume":"203","author":[{"given":"Xun-Zheng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Jun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.actbio.2025.07.055_bib0002","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/liv.15130","article-title":"Treatment and the prognosis of hepatocellular carcinoma in Asia","volume":"42","author":"Torimura","year":"2022","journal-title":"Liver. Int."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2012.05174.x","article-title":"Potentially curative treatment in patients with hepatocellular cancer\u2014Results from the liver cancer research network","volume":"36","author":"Kanwal","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.actbio.2025.07.055_bib0004","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12325-008-0113-z","article-title":"Systemic therapy of hepatocellular carcinoma: are we making progress?","volume":"25","author":"Roxburgh","year":"2008","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.actbio.2025.07.055_bib0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.crad.2017.01.013","article-title":"Loco-regional treatment of HCC: current status","volume":"72","author":"Crocetti","year":"2017","journal-title":"Clin. Radiol."},{"issue":"2","key":"10.1016\/j.actbio.2025.07.055_bib0006","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2025.07.055_bib0007","article-title":"Current status of transarterial chemoembolization (TACE) agents in hepatocellular carcinoma treatment","volume":"77","author":"Saghafian Larijani","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0008","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17425247.2021.1835858","article-title":"Drug-eluting embolic microspheres: state-of-the-art and emerging clinical applications","volume":"18","author":"Mikhail","year":"2021","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0009","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2214\/AJR.19.21669","article-title":"Drug-eluting microsphere versus cisplatin-based transarterial chemoembolization for the treatment of hepatocellular carcinoma: propensity score\u2013Matched analysis","volume":"215","author":"Chu","year":"2020","journal-title":"Am. J. Roentgenol."},{"issue":"9","key":"10.1016\/j.actbio.2025.07.055_bib0010","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/17425247.2016.1192122","article-title":"Multifunctional microbeads for drug delivery in TACE","volume":"13","author":"Bannerman","year":"2016","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"20","key":"10.1016\/j.actbio.2025.07.055_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202170137","article-title":"Precision embolism: biocompatible temperature-sensitive hydrogels as novel embolic materials for both mainstream and peripheral vessels","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2025.07.055_bib0012","first-page":"S25","article-title":"Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization","author":"K","year":"2005","journal-title":"Rev. Publ. Radiol. Soc. N. Am. Inc 25 Suppl 1"},{"issue":"8","key":"10.1016\/j.actbio.2025.07.055_bib0013","first-page":"1734","article-title":"Portal hypertension and hepatocellular carcinoma: des liaisons dangereuses\u2026","volume":"41","author":"A","year":"2021","journal-title":"Off. J. Int. Assoc. Study Liver"},{"issue":"4","key":"10.1016\/j.actbio.2025.07.055_bib0014","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14740\/jocmr2496w","article-title":"The changes of HIF-1\u03b1 and VEGF expression after TACE in patients with hepatocellular carcinoma","volume":"8","author":"Liu","year":"2016","journal-title":"J. Clin. Med. Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2010.10.005","article-title":"Trans-arterial chemoembolization as a therapy for liver tumours: new clinical developments and suggestions for combination with angiogenesis inhibitors","volume":"80","author":"Gadaleta","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"28","key":"10.1016\/j.actbio.2025.07.055_bib0016","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2217\/fon-2017-0739","article-title":"Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments","volume":"14","author":"Petrillo","year":"2018","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0017","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/10717544.2022.2081384","article-title":"Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin","volume":"29","author":"Lv","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0018","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"31","key":"10.1016\/j.actbio.2025.07.055_bib0019","doi-asserted-by":"crossref","first-page":"40641","DOI":"10.1021\/acsami.4c07503","article-title":"Peptide-IR820 conjugate: a promising strategy for efficient vascular disruption and hypoxia induction in melanoma","volume":"16","author":"Zhang","year":"2024","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.actbio.2025.07.055_bib0020","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.actbio.2025.07.055_bib0021","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cbdd.13166","article-title":"An overview on Vadimezan (DMXAA): the vascular disrupting agent","volume":"91","author":"Daei Farshchi Adli","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"15_suppl","key":"10.1016\/j.actbio.2025.07.055_bib0022","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.2035","article-title":"A phase 2 trial of TRC105 with bevacizumab for bevacizumab refractory glioblastoma","volume":"34","author":"Ahluwalia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.actbio.2025.07.055_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy","author":"Qin","year":"2024","journal-title":"Liver Int. n\/a(n\/a)"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0024","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.actbio.2025.07.055_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/07357907.2017.1364745","article-title":"Realizing the potential of vascular targeted therapy: the rationale for combining vascular disrupting agents and anti-angiogenic agents to treat cancer","volume":"35","author":"DW","year":"2017","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3816\/CLC.2005.n.032","article-title":"Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005?","volume":"7","author":"Raben","year":"2005","journal-title":"Clin. Lung Cancer"},{"issue":"22","key":"10.1016\/j.actbio.2025.07.055_bib0027","article-title":"Sandwich-structured implants to obstruct multipath energy supply and trigger self-enhanced hypoxia-initiated chemotherapy against postsurgical tumor recurrence and metastasis","volume":"10","author":"Fang","year":"2023","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.actbio.2025.07.055_bib0028","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/annonc\/mdq708","article-title":"Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer","volume":"22","author":"Zweifel","year":"2011","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.07.055_bib0029","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1628","article-title":"Disrupting tumour blood vessels","volume":"5","author":"Tozer","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"2 Pt 1","key":"10.1016\/j.actbio.2025.07.055_bib0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1078-0432.416.11.2","article-title":"Differentiation and definition of vascular-targeted therapies","volume":"11","author":"Siemann","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2025.07.055_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073765","article-title":"Anti-angiogenic therapy: current challenges and future perspectives","author":"Lopes-Coelho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.actbio.2025.07.055_bib0032","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/smll.201500324","article-title":"Coadministration of vascular disrupting agents and nanomedicines to eradicate tumors from peripheral and Central regions","volume":"11","author":"Song","year":"2015","journal-title":"Small."},{"issue":"6","key":"10.1016\/j.actbio.2025.07.055_bib0033","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2125.2011.03928.x","article-title":"A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours","volume":"71","author":"He","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.actbio.2025.07.055_bib0034","doi-asserted-by":"crossref","first-page":"18560","DOI":"10.1021\/acsami.8b04394","article-title":"Nanogel-incorporated injectable hydrogel for synergistic therapy based on sequential local delivery of combretastatin-A4 phosphate (CA4P) and doxorubicin (DOX)","volume":"10","author":"Yang","year":"2018","journal-title":"ACS. Appl. Mater. Interfaces."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0035","first-page":"19","article-title":"[A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects]","volume":"56","author":"Jiaqi","year":"1996","journal-title":"Nihon Igaku Hoshasen. Gakkai Zasshi."},{"issue":"5","key":"10.1016\/j.actbio.2025.07.055_bib0036","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00270-011-0287-7","article-title":"Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations","volume":"35","author":"Lencioni","year":"2012","journal-title":"Cardiovasc Interv. Radiol."},{"key":"10.1016\/j.actbio.2025.07.055_bib0037","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","article-title":"DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization","volume":"17","author":"Lewis","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0038","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1039\/C8BM01442F","article-title":"Enhanced local cancer therapy using a CA4P and CDDP co-loaded polypeptide gel depot","volume":"7","author":"Yu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2025.07.055_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123018","article-title":"Pickering emulsion with tumor vascular destruction and microenvironment modulation for transarterial embolization therapy","volume":"316","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.actbio.2025.07.055_bib0040","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1039\/C9BM00002J","article-title":"An eximious and affordable GSH stimulus-responsive poly(\u03b1-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy","volume":"7","author":"Liu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2025.07.055_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402253","article-title":"A study on overcoming post-TACE drug resistance in HCC based on controllable oxygen release-magnetic hyperthermia therapy","author":"Huang","year":"2024","journal-title":"Adv. Heal. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0042","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13568-021-01314-5","article-title":"Anti-tumor effect of polysaccharide from Pleurotus ostreatus on H22 mouse Hepatoma ascites in-vivo and hepatocellular carcinoma in-vitro model","volume":"11","author":"Khinsar","year":"2021","journal-title":"AMB Express."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.055_bib0043","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2018172944","article-title":"Heat stress and hepatic laser thermal ablation induce hepatocellular carcinoma growth: role of PI3K\/mTOR\/AKT signaling","volume":"288","author":"Jondal","year":"2018","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.actbio.2025.07.055_bib0044","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7150\/thno.10823","article-title":"MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors","volume":"5","author":"Kim","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2025.07.055_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153560","article-title":"Brucea javanica: a review on anticancer of its pharmacological properties and clinical researches","volume":"86","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.actbio.2025.07.055_bib0046","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/1346-8138.15516","article-title":"Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-\u03b1, interleukin (IL)-33 or IL-1\u03b2","volume":"47","author":"Kamegashira","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.actbio.2025.07.055_bib0047","article-title":"Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.07.055_bib0048","first-page":"818","article-title":"TNF-\u03b1 and HMGB1: new biomarkers of acute pulmonary embolism","volume":"51","author":"Yang","year":"2021","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.actbio.2025.07.055_bib0049","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fphar.2020.00339","article-title":"Antitumor drug combretastatin-A4 phosphate aggravates the symptoms of dextran sulfate sodium-induced ulcerative colitis in mice","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2025.07.055_bib0050","article-title":"Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis","volume":"30","author":"Huang","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"32","key":"10.1016\/j.actbio.2025.07.055_bib0051","article-title":"A study on overcoming post-TACE drug resistance in HCC based on controllable oxygen release-magnetic hyperthermia therapy","volume":"13","author":"Huang","year":"2024","journal-title":"Adv Heal. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.055_bib0052","doi-asserted-by":"crossref","DOI":"10.1111\/jfpp.12758","article-title":"Approaches to removal and killing of Salmonella Spp. Biofilms","volume":"41","author":"Speranza","year":"2017","journal-title":"J. Food Process. Preserv."},{"issue":"6","key":"10.1016\/j.actbio.2025.07.055_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325981","article-title":"Study on the relationship between viral inactivation and alkyl chain length of benzalkonium chloride","volume":"20","author":"Takada","year":"2025","journal-title":"PLoS. One"}],"updated-by":[{"DOI":"10.1016\/j.actbio.2025.11.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125005537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125005537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:40:15Z","timestamp":1768441215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125005537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"alternative-id":["S1742706125005537"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.07.055","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quaternary ammonium salt microspheres loaded with vascular disrupting agents for targeted interventional therapy of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}